Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer

It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understand...

Full description

Saved in:
Bibliographic Details
Main Authors: Athanasia Pavlidou, Nikos F. Vlahos
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/709736
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552577710948352
author Athanasia Pavlidou
Nikos F. Vlahos
author_facet Athanasia Pavlidou
Nikos F. Vlahos
author_sort Athanasia Pavlidou
collection DOAJ
description It is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.
format Article
id doaj-art-88cfef827c6e4bba913b4616a4381879
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-88cfef827c6e4bba913b4616a43818792025-02-03T05:58:19ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/709736709736Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial CancerAthanasia Pavlidou0Nikos F. Vlahos1Second Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieion University Hospital, 76 Vas. Sofias Avenue, 11527 Athens, GreeceSecond Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieion University Hospital, 76 Vas. Sofias Avenue, 11527 Athens, GreeceIt is well established that the PI3K/Akt/mTOR pathway plays a central role in cell growth and proliferation. It has also been suggested that its deregulation is associated with cancer. Genetic alterations, involving components of this pathway, are often encountered in endometrial cancers. Understanding and identifying the rate-limiting steps of this pathway would be crucial for the development of novel therapies against endometrial cancer. This paper reviews alterations in the PI3K/Akt pathway, which could possibly contribute to the development of endometrial cancer. In addition, potential therapeutic targets of this pathway with emphasis on the mTOR inhibitors are also presented.http://dx.doi.org/10.1155/2014/709736
spellingShingle Athanasia Pavlidou
Nikos F. Vlahos
Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
The Scientific World Journal
title Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
title_full Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
title_fullStr Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
title_full_unstemmed Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
title_short Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
title_sort molecular alterations of pi3k akt mtor pathway a therapeutic target in endometrial cancer
url http://dx.doi.org/10.1155/2014/709736
work_keys_str_mv AT athanasiapavlidou molecularalterationsofpi3kaktmtorpathwayatherapeutictargetinendometrialcancer
AT nikosfvlahos molecularalterationsofpi3kaktmtorpathwayatherapeutictargetinendometrialcancer